期刊
CANCER INVESTIGATION
卷 30, 期 1, 页码 27-37出版社
TAYLOR & FRANCIS INC
DOI: 10.3109/07357907.2011.629379
关键词
Autophagy; Ceramide; Glioblastoma; Glucosylceramide synthase; Temozolomide
类别
资金
- Ministry of University and Scientific and Technological Research PRIN
- FIRST
Glioblastoma is a deadly cancer with intrinsic chemoresistance. Understanding this property will aid in therapy. Glucosylceramide synthase (GCS) is associated with resistance and poor outcome; little is known about glioblastomas. In glioblastoma cells, temozolomide and paclitaxel induce ceramide increase, which in turn promotes cytotoxicity. In drug-resistant cells, both drugs are unable to accumulate ceramide, increased expression and activity of GCS is present, and its inhibitors hinder resistance. Resistant cells exhibit cross-resistance, despite differing in marker expression, and cytotoxic mechanism. These findings suggest that GCS protects glioblastoma cells against autophagic and apoptotic death, and contributes to cell survival under chemotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据